Gloucestershire Hospitals
- Healthcare professionals
- Gloucestershire Managed Services
- Our charity
- Work for us
- Staff on call
- Intranet
-
Your Visit
-
Our Services
-
About us
-
Contact us
Clopidogrel / PPI interaction
In May 2009, the EU Committee for Medicinal products for Human Use (CHMP) concluded that concomitant use of any Proton Pump Inhibitor (PPI) with clopidogrel should be avoided unless considered essential.
This was based on pharmacokinetic, pharmacodynamic, and some clinical outcome data, which demonstrated that omeprazole competitively inhibits the
CYP2C19 isoenzyme (which metabolises clopidogrel to its active metabolite); reduces the ability of clopidogrel to inhibit platelet aggregation; and reduces the beneficial effect of
clopidogrel in patients.
Join our Foundation Trust today and support our hospitals
Sign up today and stay up to date with the latest news and events.
Sign up now
BEST CARE FOR EVERYONE
- © Copyright Gloucestershire Hospitals 2021
- Accessibility
- Cookies
- Terms & Conditions
- Privacy notice
- Staff privacy notice
We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.